Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON20151Not yet recruiting
Randomised, double-blind trial of dronabinol, sponsored by CHDR in cooperation with LUMC. Primary endpoints: Resting state network activity, Arterial spin labeling cerebral blood flow and 1 more. Planned start Jan 2009; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON20151.